Inventor
MICHELI FABRIZIO
IT35 patents
⚠️ This page may combine multiple inventors who share the name “MICHELI FABRIZIO”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
GLAXO GROUP LTD
16 patentsUS7855298B2Dec 21, 2010
Azabicyclo (3.1.0.) hexane derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD11 citations82
US7253284B2Aug 7, 2007
Chemical compounds
GLAXO GROUP LTD8 citations73
US7799815B2Sep 21, 2010
Triazole derivatives as modulators of dopamine D3 receptors
GLAXO GROUP LTD7 citations72
US7279474B2Oct 9, 2007
Substituted pyrrolo[2,3-d]pyrimidines as antagonists of the corticotropin releasing factor (CRF)
GLAXO GROUP LTD9 citations71
US7462622B2Dec 9, 2008
Pyrrolo[2, 3-d] pyrimidine derivatives as corticotropin releasing factor antagonists
GLAXO GROUP LTD8 citations70
US7329667B2Feb 12, 2008
CRF receptor antagonists
GLAXO GROUP LTD4 citations62
US7803820B2Sep 28, 2010
3-triazolylthiaalkyl-3-azabicyclo (3-1-O) hexanes and their use as dopamine D3 receptor ligands
GLAXO GROUP LTD5 citations61
US7863299B2Jan 4, 2011
Triazolyl derivatives of azabicyclo [3.1.0] hexane as dopamine D3 receptor modulators
GLAXO GROUP LTD6 citations60
US7745458B2Jun 29, 2010
Azabicyclo (3, 1, 0) hexan derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD2 citations60
US7727988B2Jun 1, 2010
Azabicyclo[3.1.0]hex-3-yl}alkyl)pyrimidinedione
GLAXO GROUP LTD5 citations60
US7875643B2Jan 25, 2011
Azabicyclo (3.1.0) hexane derivatives useful as modulators of dopamine D3 receptors
GLAXO GROUP LTD6 citations57
US8003638B2Aug 23, 2011
7-pyrazolylbenzazepines having affinity for D3 receptor
GLAXO GROUP LTD0 citations51
US7807698B2Oct 5, 2010
Azabicyclo[3.1.0]hexane derivatives as modulators of the dopamine D3 receptor
GLAXO GROUP LTD1 citations51
US7776904B2Aug 17, 2010
Azabicyclo [3.1.0] hexylphenyl derivatives as modulators of dopamine D3 receptors
GLAXO GROUP LTD0 citations50
US8030322B2Oct 4, 2011
Spirocompounds useful as modulators for dopamine D3 receptors
GLAXO GROUP LTD0 citations40
US7989444B2Aug 2, 2011
Compounds having affinity for dopamine D3 receptor and uses thereof
GLAXO GROUP LTD0 citations39
INDIVIOR UK LTD
6 patentsUS10000477B2Jun 19, 2018
Dopamine D3 receptor antagonist compounds
INDIVIOR UK LTD2 citations70
US10239870B2Mar 26, 2019
Dopamine D3 receptor antagonists
INDIVIOR UK LTD1 citations67
US10273244B2Apr 30, 2019
Substituted hexahydropyrrolo[3,4-b]pyrroles and hexahydrocyclopenta[c]pyrroles as dopamine receptor modulators
INDIVIOR UK LTD1 citations59
US10654842B2May 19, 2020
Dopamine D3 receptor antagonist compounds
INDIVIOR UK LTD0 citations49
US10584135B2Mar 10, 2020
Substituted 3,6-diazabicyclo[3.2.0]heptanes
INDIVIOR UK LTD0 citations49
US10577361B2Mar 3, 2020
Dopamine D3 receptor antagonists having a morpholine moiety
INDIVIOR UK LTD0 citations34
CHRONOS THERAPEUTICS LTD
3 patentsUS11660293B2May 30, 2023
Substituted 2-azabicyclo[3.1.1]heptane and 2-azabicyclo[3.2.1]octane derivatives as orexin receptor antagonists
CHRONOS THERAPEUTICS LTD0 citations47
US9908897B2Mar 6, 2018
Spirocyclic derivatives
CHRONOS THERAPEUTICS LTD0 citations33
US9920053B2Mar 20, 2018
N-(hetero)aryl-substituted heteroyclic derivatives useful for the treatment of diseases or conditions related to the central nervous system
CHRONOS THERAPEUTICS LTD0 citations31
BERTANI BARBARA
3 patentsUS8222266B2Jul 17, 2012
Azabicyclo [3.1.0] hexyl derivatives as modulators of dopamine D3 receptors
BERTANI BARBARA0 citations37
US8163927B2Apr 24, 2012
Azabicyclo [3.1.0] hexane derivatives as modulators of dopamine D3 receptors
BERTANI BARBARA0 citations37
US8178549B2May 15, 2012
Azabicyclo [3. 1. O] hexyl derivatives as modulators of dopamine D3 receptors
BERTANI BARBARA0 citations31